NAMS MENOPAUSE CERTIFICATION
EXAM
120+ (Fully Updated 2026) Exam Questions + Verified & Rationalized
Answers | A+ Graded
100% Guarantee Pass
📋 DOCUMENT OVERVIEW 120 Qs
This document covers topics related to menopause, including bone loss, menstrual migraine treatment,
female pattern hair loss (FPHL) treatment, the climacteric phase, hormone replacement therapy (HRT)
risks, and menopausal stage identification. The "NAMs Menopause Certification Exam" provides 120
questions with correct answers and detailed explanations, offering a comprehensive review of
menopause-related concepts for exam preparation and understanding. Students can use this document
to study, review, and gain a deeper understanding of the subject matter, enhancing their knowledge and
preparation for certification exams.
✓ Verified Answers ✓ Exam Ready ✓ Study Guide
Trusted by thousands of students and professionals worldwide
EXAM QUESTIONS
QUESTION 1
What percentage of bone loss do women have from the menopause transition?
CORRECT ANSWER
10-12% on average, about 1 t score
RATIONALE: The "1 t score" refers to a decrease of 1 standard deviation in bone mineral density, which is a common
measurement used to assess bone loss. This 1 t score corresponds to a 10-12% loss in bone density, making it a
reliable estimate of the average bone loss women experience during the menopause transition.
QUESTION 2
Menstrual migraine treatment
CORRECT ANSWER
Trusted by thousands of students and professionals worldwide Page 1 of 33
, NSAID or triptan 2 days before expected to get your period, and take for 5-7 days.
RATIONALE: This recommendation is based on the understanding that menstrual migraines are often triggered by
prostaglandins, hormone-like substances released by the uterus before menstruation, which can cause blood vessels to
constrict and lead to migraine pain. By taking NSAIDs or triptans before the onset of menstruation, these substances
can be mitigated, reducing the likelihood and severity of migraine symptoms.
QUESTION 3
Treating FPHL
CORRECT ANSWER
MINOXIDIL
spironolactone
finasteride
RATIONALE: FPHL (Female Pattern Hair Loss) is a condition characterized by androgenetic alopecia, and these
medications target the underlying hormonal and hormonal-receptor interactions driving hair loss. Minoxidil,
spironolactone, and finasteride are all FDA-approved treatments that address different aspects of FPHL, with minoxidil
promoting hair growth, spironolactone blocking androgens, and finasteride inhibiting 5-alpha-reductase to decrease
dihydrotestosterone (DHT) levels.
QUESTION 4
Climacteric phase
CORRECT ANSWER
The period of endrocrinologic, somatic, and transitory psychologic changes that occur around the time of
menopause.
RATIONALE: The term "climacteric phase" accurately describes the period due to its specific reference to endocrine,
somatic, and transient psychological changes that occur simultaneously, highlighting the complex interplay of physical
and emotional factors. This definition distinguishes the climacteric phase from other menopause-related changes,
emphasizing its unique blend of hormonal, physiological, and psychological transformations.
QUESTION 5
What HRT can increase your risk for dementia based on the WHIMS study in 65+ year old healthy
women?
CORRECT ANSWER
EPT replacement was shown to double the risk of developing dementia.
There was no significant increased risk in ET alone.
this is why HRT is not recommended after 65 for primary prevention of dementia
Trusted by thousands of students and professionals worldwide Page 2 of 33
, RATIONALE: The WHIMS study found that estrogen plus progestin (EPT) therapy, but not estrogen therapy (ET) alone,
significantly increased the risk of dementia in postmenopausal women over 65 years old. This distinction is crucial
because it implies that the combination of estrogen and progestin, rather than estrogen alone, is the primary factor
contributing to the increased dementia risk, leading to the conclusion that HRT with EPT should be avoided after 65 for
primary prevention of dementia.
QUESTION 6
Over 3 servings of alcohol daily and risk for fracture?
CORRECT ANSWER
38% for osteoporotic fracture and 68% for hip fracture
RATIONALE: This answer is likely based on a specific study or data that found a significant correlation between
excessive alcohol consumption (over 3 servings daily) and an increased risk of osteoporotic fractures, which accounted
for 38% of the cases, and hip fractures, which accounted for 68% due to the higher severity and vulnerability of the hip
area. The percentages represent the proportion of fractures attributed to excessive alcohol consumption in the study
population, providing a quantitative measure of the association between the two variables.
QUESTION 7
How long can it take for arthralgia from vitamin d deficiency or hypothyroidism to fully resolve?
CORRECT ANSWER
it can take several months.
RATIONALE: Arthralgia from vitamin D deficiency or hypothyroidism can take several months to fully resolve because
these conditions involve chronic inflammation and tissue damage, which require extended periods of treatment and
correction to heal. The underlying hormonal imbalances and deficiencies need to be adequately addressed, and the
body's tissue damage and inflammation need sufficient time to repair and recover.
QUESTION 8
HSDD and FSAD were combined into a single dysrunction called
CORRECT ANSWER
female sexual interest/arousal disorder
RATIONALE: Female Sexual Interest/Arousal Disorder (FSAD) is the correct answer because it is the current term for
what was previously referred to as Hypoactive Sexual Desire Disorder (HSDD) when it was combined with another
sexual dysfunction. This change occurred in the Diagnostic and Statistical Manual of Mental Disorders (DSM) to provide
a more inclusive and accurate diagnosis for female sexual dysfunctions.
QUESTION 9
all adults born from what year to what year should recieve one time hep c testing?
CORRECT ANSWER
1945 to 1965
Trusted by thousands of students and professionals worldwide Page 3 of 33
, RATIONALE: The correct answer "1945 to 1965" is based on the birth cohort approach, which targets individuals born
during the peak years of the hepatitis C virus (HCV) epidemic in the US, when injection drug use and other high-risk
behaviors were more prevalent. This timeframe coincides with the period when HCV was most likely to be transmitted to
adults, making it a strategic focus for one-time testing and potential treatment and prevention efforts.
QUESTION 10
Which topical vaginal estrogen has the highest dose?
CORRECT ANSWER
the vaginal rings
FEMRING IS THE HIGHEST
RATIONALE: The vaginal ring FEMRING has the highest dose because it typically contains 2.14 mg of estradiol, a higher
dose compared to other topical vaginal estrogen products. This is due to its unique design as a higher-dose ring that is
inserted into the vagina for an extended period, allowing for sustained release of estrogen.
QUESTION 11
HSDD treatments
CORRECT ANSWER
flibanserin and bremelanotide
RATIONALE: Flibanserin and bremelanotide are correct answers to the question "HSDD treatments" because they are
FDA-approved medications specifically designed to treat Hypoactive Sexual Desire Disorder (HSDD), a condition
characterized by a persistent low sex drive in women. These medications work by targeting the brain's
neurotransmitters and hormonal systems to increase sexual desire and satisfaction, making them effective treatments
for HSDD.
QUESTION 12
treatment of POI
CORRECT ANSWER
100 microgram estradiol patch
1.25 mg CEE
2mg oral estradiol
If intact uterus-progesterone for 12 days of the month.
Physiologic is better than continuous hormonal contractption, but if menorrhagia-IUD plus estrogen
patch, or if really not wanting to risk pregnancy, continuous HRT can be used.
RATIONALE: This treatment approach for Postmenopausal Osteoporosis (POI) acknowledges that physiologic hormone
replacement therapy is generally preferred, as it mimics the body's natural hormonal fluctuations, but also provides
alternative options for women with heavy bleeding or those who do not want to risk pregnancy. The use of combined
estrogen and progesterone treatments aims to alleviate menopausal symptoms while protecting against endometrial
hyperplasia and maintaining bone density in osteoporotic patients.
QUESTION 13
Trusted by thousands of students and professionals worldwide Page 4 of 33
EXAM
120+ (Fully Updated 2026) Exam Questions + Verified & Rationalized
Answers | A+ Graded
100% Guarantee Pass
📋 DOCUMENT OVERVIEW 120 Qs
This document covers topics related to menopause, including bone loss, menstrual migraine treatment,
female pattern hair loss (FPHL) treatment, the climacteric phase, hormone replacement therapy (HRT)
risks, and menopausal stage identification. The "NAMs Menopause Certification Exam" provides 120
questions with correct answers and detailed explanations, offering a comprehensive review of
menopause-related concepts for exam preparation and understanding. Students can use this document
to study, review, and gain a deeper understanding of the subject matter, enhancing their knowledge and
preparation for certification exams.
✓ Verified Answers ✓ Exam Ready ✓ Study Guide
Trusted by thousands of students and professionals worldwide
EXAM QUESTIONS
QUESTION 1
What percentage of bone loss do women have from the menopause transition?
CORRECT ANSWER
10-12% on average, about 1 t score
RATIONALE: The "1 t score" refers to a decrease of 1 standard deviation in bone mineral density, which is a common
measurement used to assess bone loss. This 1 t score corresponds to a 10-12% loss in bone density, making it a
reliable estimate of the average bone loss women experience during the menopause transition.
QUESTION 2
Menstrual migraine treatment
CORRECT ANSWER
Trusted by thousands of students and professionals worldwide Page 1 of 33
, NSAID or triptan 2 days before expected to get your period, and take for 5-7 days.
RATIONALE: This recommendation is based on the understanding that menstrual migraines are often triggered by
prostaglandins, hormone-like substances released by the uterus before menstruation, which can cause blood vessels to
constrict and lead to migraine pain. By taking NSAIDs or triptans before the onset of menstruation, these substances
can be mitigated, reducing the likelihood and severity of migraine symptoms.
QUESTION 3
Treating FPHL
CORRECT ANSWER
MINOXIDIL
spironolactone
finasteride
RATIONALE: FPHL (Female Pattern Hair Loss) is a condition characterized by androgenetic alopecia, and these
medications target the underlying hormonal and hormonal-receptor interactions driving hair loss. Minoxidil,
spironolactone, and finasteride are all FDA-approved treatments that address different aspects of FPHL, with minoxidil
promoting hair growth, spironolactone blocking androgens, and finasteride inhibiting 5-alpha-reductase to decrease
dihydrotestosterone (DHT) levels.
QUESTION 4
Climacteric phase
CORRECT ANSWER
The period of endrocrinologic, somatic, and transitory psychologic changes that occur around the time of
menopause.
RATIONALE: The term "climacteric phase" accurately describes the period due to its specific reference to endocrine,
somatic, and transient psychological changes that occur simultaneously, highlighting the complex interplay of physical
and emotional factors. This definition distinguishes the climacteric phase from other menopause-related changes,
emphasizing its unique blend of hormonal, physiological, and psychological transformations.
QUESTION 5
What HRT can increase your risk for dementia based on the WHIMS study in 65+ year old healthy
women?
CORRECT ANSWER
EPT replacement was shown to double the risk of developing dementia.
There was no significant increased risk in ET alone.
this is why HRT is not recommended after 65 for primary prevention of dementia
Trusted by thousands of students and professionals worldwide Page 2 of 33
, RATIONALE: The WHIMS study found that estrogen plus progestin (EPT) therapy, but not estrogen therapy (ET) alone,
significantly increased the risk of dementia in postmenopausal women over 65 years old. This distinction is crucial
because it implies that the combination of estrogen and progestin, rather than estrogen alone, is the primary factor
contributing to the increased dementia risk, leading to the conclusion that HRT with EPT should be avoided after 65 for
primary prevention of dementia.
QUESTION 6
Over 3 servings of alcohol daily and risk for fracture?
CORRECT ANSWER
38% for osteoporotic fracture and 68% for hip fracture
RATIONALE: This answer is likely based on a specific study or data that found a significant correlation between
excessive alcohol consumption (over 3 servings daily) and an increased risk of osteoporotic fractures, which accounted
for 38% of the cases, and hip fractures, which accounted for 68% due to the higher severity and vulnerability of the hip
area. The percentages represent the proportion of fractures attributed to excessive alcohol consumption in the study
population, providing a quantitative measure of the association between the two variables.
QUESTION 7
How long can it take for arthralgia from vitamin d deficiency or hypothyroidism to fully resolve?
CORRECT ANSWER
it can take several months.
RATIONALE: Arthralgia from vitamin D deficiency or hypothyroidism can take several months to fully resolve because
these conditions involve chronic inflammation and tissue damage, which require extended periods of treatment and
correction to heal. The underlying hormonal imbalances and deficiencies need to be adequately addressed, and the
body's tissue damage and inflammation need sufficient time to repair and recover.
QUESTION 8
HSDD and FSAD were combined into a single dysrunction called
CORRECT ANSWER
female sexual interest/arousal disorder
RATIONALE: Female Sexual Interest/Arousal Disorder (FSAD) is the correct answer because it is the current term for
what was previously referred to as Hypoactive Sexual Desire Disorder (HSDD) when it was combined with another
sexual dysfunction. This change occurred in the Diagnostic and Statistical Manual of Mental Disorders (DSM) to provide
a more inclusive and accurate diagnosis for female sexual dysfunctions.
QUESTION 9
all adults born from what year to what year should recieve one time hep c testing?
CORRECT ANSWER
1945 to 1965
Trusted by thousands of students and professionals worldwide Page 3 of 33
, RATIONALE: The correct answer "1945 to 1965" is based on the birth cohort approach, which targets individuals born
during the peak years of the hepatitis C virus (HCV) epidemic in the US, when injection drug use and other high-risk
behaviors were more prevalent. This timeframe coincides with the period when HCV was most likely to be transmitted to
adults, making it a strategic focus for one-time testing and potential treatment and prevention efforts.
QUESTION 10
Which topical vaginal estrogen has the highest dose?
CORRECT ANSWER
the vaginal rings
FEMRING IS THE HIGHEST
RATIONALE: The vaginal ring FEMRING has the highest dose because it typically contains 2.14 mg of estradiol, a higher
dose compared to other topical vaginal estrogen products. This is due to its unique design as a higher-dose ring that is
inserted into the vagina for an extended period, allowing for sustained release of estrogen.
QUESTION 11
HSDD treatments
CORRECT ANSWER
flibanserin and bremelanotide
RATIONALE: Flibanserin and bremelanotide are correct answers to the question "HSDD treatments" because they are
FDA-approved medications specifically designed to treat Hypoactive Sexual Desire Disorder (HSDD), a condition
characterized by a persistent low sex drive in women. These medications work by targeting the brain's
neurotransmitters and hormonal systems to increase sexual desire and satisfaction, making them effective treatments
for HSDD.
QUESTION 12
treatment of POI
CORRECT ANSWER
100 microgram estradiol patch
1.25 mg CEE
2mg oral estradiol
If intact uterus-progesterone for 12 days of the month.
Physiologic is better than continuous hormonal contractption, but if menorrhagia-IUD plus estrogen
patch, or if really not wanting to risk pregnancy, continuous HRT can be used.
RATIONALE: This treatment approach for Postmenopausal Osteoporosis (POI) acknowledges that physiologic hormone
replacement therapy is generally preferred, as it mimics the body's natural hormonal fluctuations, but also provides
alternative options for women with heavy bleeding or those who do not want to risk pregnancy. The use of combined
estrogen and progesterone treatments aims to alleviate menopausal symptoms while protecting against endometrial
hyperplasia and maintaining bone density in osteoporotic patients.
QUESTION 13
Trusted by thousands of students and professionals worldwide Page 4 of 33
